The role of activation-induced deaminase in Lupus Nephritis

Autoimmunity

Volumn 46, Issue 2, 2013, Pages 115-120

  Diaz, Marilyn ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

AID; Antibodies; Glomerulonephritis; Lupus; Somatic mutation

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY AFFINITY; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; ENZYME DEFICIENCY; GLOMERULONEPHRITIS; GLOMERULUS; HUMAN; IMMUNOPATHOGENESIS; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE STRAIN; NONHUMAN; PROTEIN FUNCTION; REVIEW; SOMATIC HYPERMUTATION; SURVIVAL;

ANIMALS; ANTIBODIES; AUTOANTIBODIES; AUTOIMMUNITY; CYTIDINE DEAMINASE; ENZYME ACTIVATION; HUMANS; IMMUNOGLOBULIN M; LUPUS NEPHRITIS;

EID: 84873636012     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2012.750303     Document Type: Review

References (50)

1. Koffler, D., P. H. Schur, and H. G. Kunkel. 1967. Immunological studies concerning the nephritis of systemic lupus erythematosus. J. Exp. Med 126: 607-624
2. Koffler, D., V. Agnello, and H. G. Kimkel. 1974. Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus. Am. J. Pathol 74: 109-124
3. Lloyd, W., and P. H. Schur. 1981. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine (Baltimore) 60: 208-217
4. van Es, J. H., F. H. Gmelig Meyling,W. R. van de Akker, et al. 1991. Somatic mutations in the variable regions of a human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus. J. Exp. Med 173: 461-470
5. Winkler, T. H., H. Fehr, and J. R. Kalden. 1992. Analysis of immunoglobulin variable region genes from human IgG anti-DNA hybridomas. Eur. J. Immunol 22: 1719-1728
6. Wellmann, U., M. Letz, M. Herrmann, et al. 2005. The evolution of human anti-double-stranded DNA autoantibodies. Proc. Natl. Acad. Sci. USA 102: 9258-9263
7. Chen, C., Z. Nagy, M. Z. Radic, et al. 1995. The site and stage of anti-DNA B-cell deletion. Nature 373: 252-255
8. Culton, D. A., B. P. O'Conner, K. L. Conway, et al. 2006. Early preplasma cells define a tolerance checkpoint for autoreactive B cells. J. Immunol 176: 790-802
9. Li, Y., H. Li, D. Ni, and M. Weigert. 2002. Anti-DNA B cells in MRL/lpr mice show altered differentiation and editing pattern. J. Exp. Med 196: 1543-1552
10. Mandik-Nayak, L., S. J. Seo, C. Sokol, et al. 1999. MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J. Exp. Med 189: 1799-1814
11. Bao, L., I. Osawe, M. Haas, and R. J. Quigg. 2005. Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis. J. Immunol 175: 1947-1955
12. Pickering, M. C., M. Botto, P. R. Taylor, P. J. Lachmann, and M. J. Walport. 2000. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv. Immunol 76: 227-324
13. Watanabe, H., G. Garnier, A. Circolo, et al. 2000. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J. Immunol 164: 786-794
14. Pascual, V., J. Banchereau, and A. K. Palucka. 2003. The central role of dendritic cells and interferon-alpha in SLE. Curr. Opin. Rheumatol 15: 548-556
15. Theofilopoulos, A. N., and B. R. Lawson. 1999. Tumour necrosis factor and other cytokines in murine lupus. Ann. Rheum. Dis 58 Suppl 1: I49-I55
16. Chan, O. T., L. G. Hannum, A. M. Haberman, M. P. Madaio, and M. J. Shlomchik. 1999. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med 189: 1639-1648
17. Muramatsu, M., K. Kinoshita, S. Fagarasan, et al. 2000. Class switch recombination and hypermutation require activationinduced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563
18. Revy, P., T. Muto, Y. Levy, et al. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102: 565-575
19. Eisen, H. N., and G. W. Siskind. 1964. Variations in affinities of antibodies during the immune response. Biochemistry 3: 9961008
20. Klinman,N. R. 1972. The mechanism of antigenic stimulation of primary and secondary clonal precursor cells. J. Exp. Med 136: 241-260
21. Weigert, M. G., I. M. Cesari, S. J. Yonkovich, and M. Cohn. 1970. Variability in the lambda light chain sequences of mouse antibody. Nature 228: 1045-1047
22. Crews, S., J. Griffin, H. Huang, K. Calame, and L. Hood. 1981. A single VH gene segment encodes the immune response to phosphorylcholine: somatic mutation is correlated with the class of the antibody. Cell 25: 59-66
23. Berek, C., A. Berger, and M. Apel. 1991. Maturation of the immune response in germinal centers. Cell 67: 1121-1129
24. Chaudhuri, J., and F. W. Alt. 2004. Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat. Rev. Immunol 4: 541-552
25. Kataoka, T., T. Miyata, and T. Honjo. 1981. Repetitive sequences in class-switch recombination regions of immunoglobulin heavy chain genes. Cell 23: 357-368
26. Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol 37: 269-390
27. Andrews, B. S., R. A. Eisenberg, A. N. Theofilopoulos, et al. 1978. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med 148: 1198-1215
28. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317
29. Jiang, C., J. Foley, N. Clayton, et al. 2007. Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice. J. Immunol 178: 7422-7431
30. Jiang, C., M. L. Zhao, and M. Diaz. 2009. Activation-induced deaminase heterozygous MRL/lpr mice are delayed in the production of high-affinity pathogenic antibodies and in the development of lupus nephritis. Immunology 126: 102-113
31. Zan, H., J. Zhang, S. Ardeshna, et al. 2009. Lupus-prone MRL/faslpr/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: concurrent upregulation of somatic hypermutation and class switch DNA recombination. Autoimmunity 42: 89-103
32. Boes, M., T. Schmidt, and K. Linkemann. 2000. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc. Natl. Acad. Sci. USA 97: 1184-1189
33. Melamed, D., E. Miri, N. Leider, and D. Nemazee. 2000. Unexpected autoantibody production in membrane Ig-mu-deficient/lpr mice. J. Immunol 165: 4353-4358
34. Forger, F., T. Matthias, M. Oppermann, H. Becker, and K. Helmke. 2004. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis. Lupus 13: 36-44
35. Jiang, C., M. L. Zhao, R. M. Scearce, and M. Diaz. 2011. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis. Arthritis Rheum 63: 1086-1096
36. Jiang, C., M. L. Zhao, K. M. Waters, and M. Diaz. 2012. Activation-induced deaminase contributes to the antibodyindependent role of B cells in the development of autoimmunity. Autoimmunity 45: 440-448
37. Guo, W., D. Smith, K. Aviszus, et al. 2010. Somatic hypermutation as a generator of antinuclear antibodies in a murine model of systemic autoimmunity. J. Exp. Med 207: 2225-2237
38. Sims, G. P., H. Shiono, N. Willcox, and D. I. Stott. 2001. Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis. J. Immunol 167: 1935-1944
39. Stott, D. I., F. Hiepe, M. Hummel, G. Steinhauser, and C. Berek. 1998. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjogren's syndrome. J. Clin. Invest 102: 938-946
40. Kim, H. J., and C. Berek. 2000. B cells in rheumatoid arthritis. Arthritis Res 2: 126-131
41. Gronwall, C., J. Vas, and G. J. Silverman. 2012. Protective roles of natural IgM antibodies. Front Immunol 3: 66
42. Chong, B. F., L. C. Tseng, T. Lee, et al. 2012. IgG and IgM autoantibody differences in discoid and systemic lupus patients. J. Invest. Dermatol. Epub ahead of print
43. Quartier, P., J. Bustamante, O. Sanal, et al. 2004. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency. Clin. Immunol 110: 22-29
44. Kuraoka, M., T. M. Holl, D. Liao, et al. 2011. Activationinduced cytidine deaminase mediates central tolerance in B cells. Proc. Natl. Acad. Sci. USA 108: 11560-11565
45. Muramatsu, M., V. S. Sankaranand, S. Anant, et al. 1999. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem 274: 18470-18476
46. Crouch, E. E., Z. Li, M. Takizawa, et al. 2007. Regulation of AID expression in the immune response. J. Exp. Med 204: 1145-1156
47. Muto, T., M. Muramatsu, M. Taniwaki, K. Kinoshita, and T. Honjo. 2000. Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene. Genomics 68: 85-88
48. Arkwright, P. D., M. Abinun, and A. J. Cant. 2002. Autoimmunity in human primary immunodeficiency diseases. Blood 99: 2694-2702
49. Patiroglu, T., H. E. Gungor, and E. Unal. 2012. Autoimmune diseases detected in children with primary immunodeficiency diseases: results from a reference centre at middle anatolia. Acta Microbiol. Immunol. Hung 59: 343-353
50. Cunningham-Rundles, C. 2002. Hematologic complications of primary immune deficiencies. Blood Rev 16: 61-64